Incidence and Risk Factor of Hydroxychloroquine and Chloroquine Retinopathy

UnknownOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Toxic Maculopathy
Interventions
PROCEDURE

Composite Examination

First, patients will get the baseline ophthalmologic exam and medical evaluation by physicians. As a diagnostic method, the composite examination including fundus photography, fundus autofluorescence, spectral-domain optical coherence tomography, Humphrey visual field test and multifocal electroretinography will be tested once every year.

Trial Locations (1)

05505

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER